Urticaria: all 239 studies
Page 2 of 3. Open to participants first (26), then studies with results posted, then the rest; newest registration first within each.
- A Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients With Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite Treatment With H1- AntihistaminesTerminatedNCT06353971Phase 1/2
- Antiplatelet Therapy in Chronic UrticariaActive, not recruitingNCT06268470Phase 2
- Dose Escalation Trial Of Safety, Pharmacokinetic/Pharmacodynamic And Preliminary Clinical Activity of Briquilimab In Adult Patients With Chronic Spontaneous Urticaria (CSU)CompletedNCT06162728Phase 1/2
- Non-invasive Diagnosis of Cold UrticariaActive, not recruitingNCT06127992Not applicable
- Improving Health and Wellbeing for People Diagnosed With Chronic Spontaneous Urticaria (CSU)SuspendedNCT06108869Not applicable
- Study to Assess the Safety, Tolerability, Pharmacokinetics and Immunogenicity of AK006 in Healthy Subjects and Subjects With Chronic Spontaneous UrticariaCompletedNCT06072157Phase 1
- Food-specific IgG4-guided Elimination Diets Improve Allergy Symptoms in ChildrenCompletedNCT06063044
- Phase 1b, Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Chronic Inducible UrticariaCompletedNCT06050928Phase 1
- Phase 3b Study to Assess the Efficacy, Safety, and Tolerability of Remibrutinib in Comparison to Placebo, With Omalizumab as Active Control, in Adult CSU Patients, Followed by an Open-label 52-week Optional Extension.Active, not recruitingNCT06042478Phase 3
- A Single Dose, Phase 1 Study of YH35324 in Patients with Various Allergic DiseasesCompletedNCT05960708Phase 1
- Study to Compare Efficacy Safety and Immunogenicity of ADL-018 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic UrticariaCompletedNCT05774639Phase 3
- Positive Psychotherapy-Based Counseling (PPT)Status unknownNCT05513079Not applicable
- A Study to Evaluate THB001 in Adult Patients With Chronic Cold UrticariaTerminatedNCT05510843Phase 1
- Bioavailability and Tolerability of Fexofenadine Hydrochloride Topical Lotion 1%CompletedNCT05461456Phase 1
- Safety and Efficacy of TLL018 in Patients With Chronic Spontaneous Urticaria.CompletedNCT05373355Phase 1
- A Phase 2 Study of CDX-0159 in Patients With Chronic Spontaneous UrticariaCompletedNCT05368285Phase 2
- A Phase 2a Study of TAS5315 in Patients With Chronic Spontaneous UrticariaCompletedNCT05335499Phase 2
- A Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Efficacy of UB-221 IV Infusion as an add-on Therapy in Patients With Chronic Spontaneous UrticariaStatus unknownNCT05298215Phase 2
- STOP CSUA: phySical acTivity, mOod and sleeP in Chronic Spontaneous Urticaria and AngioedemaStatus unknownNCT05169645
- A Study of MTPS9579A in Participants With Refractory Chronic Spontaneous UrticariaWithdrawnNCT05129423Phase 2
- Using Doxepin for UrticariaStatus unknownNCT05115136Phase 3
- Ocular and Palpebral Manifestations of Mastocytosis (MOOMA)CompletedNCT04978740Not applicable
- Study to Evaluate the Therapeutic Equivalence of SYN008 Versus Xolair® in the Treatment of Patients With Refractory Chronic Spontaneous UrticariaStatus unknownNCT04944602Phase 3
- Study on the Correlation Between Intestinal Microecology and Allergic Diseases in ChildrenStatus unknownNCT04938700Phase 4
- Global Managed Access Program Cohort for Ligelizumab in CSUNo longer availableNCT04903613
- Efficacy of Low-dose Interleukin-2 Treatment in Chronic Spontaneous UrticariaStatus unknownNCT04893980Phase 2/3
- Study to Evaluate the Efficacy, Safety, and Tolerability of Tirabrutinib in Participants With Antihistamine-Resistant Chronic Spontaneous UrticariaWithdrawnNCT04827589Phase 2
- Molecular Endotypes of Chronic Idiopathic UrticariaActive, not recruitingNCT04774315Phase 4
- Real Life Use of Omalizumab in Chronic UrticariaStatus unknownNCT04584190
- A Single Dose Study of the Safety, Pharmacokinetics and Pharmacodynamics of CDX-0159 in Patients With Cold Contact Urticaria, Symptomatic Dermographism, or Cholinergic UrticariaCompletedNCT04548869Phase 1
- A Study of CDX-0159 in Patients With Chronic Spontaneous UrticariaCompletedNCT04538794Phase 1
- Study of Mechanism of Action of Ligelizumab (QGE031) in Patients With Chronic UrticariaTerminatedNCT04513548Phase 1
- A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UCB8600 in Healthy Participants, Atopic Participants, and Chronic Spontaneous Urticaria ParticipantsTerminatedNCT04444466Phase 1
- Study to Evaluate the Safety, Tolerability and Efficacy of Cannabidiol (CBD) as a Steroid-sparing Therapy in Chronic Spontaneous Urticaria (CSU) PatientsCompletedNCT04439955Phase 2
- Frequency of Parasite Infestation in Patients With Chronic Spontaneous UrticariaCompletedNCT04314999
- Study of the Efficacy and Safety of RPH-104 in Adult Subjects With Schnitzler SyndromeWithdrawnNCT04213274Phase 2
- Shotblocker® Use in Subcutaneous InjectionCompletedNCT04210323Not applicable
- A Trial to Evaluate the Effect of Vitamin D Supplementation in Patients With Chronic UrticariaStatus unknownNCT03991845Phase 4
- Characteristics of Patients Diagnosed With NSAID Sensitivity in ThailandCompletedNCT03849625
- Tranexamic Acid and Spontaneous Chronic UrticariaStatus unknownNCT03789422Phase 4
- Cholinergic Urticaria - Efficacy of DupilumabCompletedNCT03749148Phase 2
- Dupilumab in Chronic Spontaneous UrticariaCompletedNCT03749135Phase 2
- Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of UB-221 as an Add-on Therapy in CSU PatientsCompletedNCT03632291Phase 1
- COrticosteroids in acUte uRticAria in emerGency dEpartmentCompletedNCT03545464Phase 3
- Role of Endothelial Cells in the Pathogenesis of Chronic Urticaria.Status unknownNCT03443362
- Patient Centered Care Situation and Health-related Quality of Life by Patients With Psoriasis, Urticaria or LupusCompletedNCT03324919
- Adding a Short Burst of Corticosteroid to the Conventional Treatment of H1 Antihistamines in Emergency Department.CompletedNCT03296358Not applicable
- Efficacy of Antihistamine Dosing-up and add-on Treatment With H2-receptor AntagonistCompletedNCT03293225
- To Assess and Compare the Efficacy of Cyclosporine Versus Azathioprine in the Treatment of Chronic Refractory UrticariaCompletedNCT03250143Phase 1/2
- Treatment of Chronic Urticarial Unresponsive to H1-antihistamines With an Anti-IL5Ralpha Monoclonal AntibodyCompletedNCT03183024Phase 4
- Quality of Life in Patients With Chronic UrticariaStatus unknownNCT03163875
- Animal Allergy in Korean Pet Owners, Pet-related Industry Workers, and Laboratory Animal ReseachersCompletedNCT03101618
- Role of Circulating Innate Lymphoid Cells in Allergic DisordersTerminatedNCT03069495
- The Role of the Coagulation Pathways in Recurrent AngioedemaTerminatedNCT02892682Not applicable
- High Dose Vitamin D Supplementation in Chronic Spontaneous UrticariaStatus unknownNCT02873364Phase 3
- Animal Allergy in Korean Veterinary ResearcherCompletedNCT02866864
- Experimental Autologous Mesenchymal Stem Cell Therapy in Treatment of Chronic Autoimmune UrticariaCompletedNCT02824393Early Phase 1
- Three-month, Single-center Study to Identify Biomarkers/Response to Xolair Therapy in Chronic Idiopathic UrticariaCompletedNCT02814630Not applicable
- Cutaneous Mastocytosis in Children: Analysis of Somatic and Germline MutationsCompletedNCT02761473
- Sustained Effect of Urticaria Remission With Relatively High Dose Vitamin D Supplementation After Omalizumab DiscontinuationWithdrawnNCT02742805Phase 4
- Monitoring Chronic Urticaria Basophil Irritability by CytometryCompletedNCT02671006
- A Worldwide Antihistamine-Refractory Chronic Urticaria Patient Evaluation in Latin America and Canada (AWARE-LACan)CompletedNCT02626221
- Glucocorticoids With Antihistamines Versus Antihistamines in Acute Urticaria in EmergencyCompletedNCT02565680Phase 2/3
- Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity SyndromeStatus unknownNCT02550080Phase 4
- AWARE - Chronic UrticariaCompletedNCT02435238
- Brief Behavioral Activation Intervention for Depressed Asthma and Urticaria PatientsTerminatedNCT02382562Not applicable
- Efficacy of Levocetirizine Fourfold Dosage in Chronic Spontaneous UrticariaCompletedNCT02372604Phase 3
- Chronic Urticaria - Long Term Assessment of Effects of RupatadineTerminatedNCT02358265Phase 3
- Cross-Cultural of the Validity, Reliability and Interpretability of Thai-version of Urticaria Control TestCompletedNCT02285049
- Study to Investigate the Safety and Efficacy of Alesion® in Japanese Paediatric Patients With UrticariaCompletedNCT02238249
- Bilastine Updosing in Chronic Spontaneous UrticariaCompletedNCT02213367Phase 3
- Efficacy and Safety of Omalizumab in Patients With Severe Acute UrticariaStatus unknownNCT02191072Not applicable
- Cold Contact Urticaria Treatment With RilonaceptCompletedNCT02171416Phase 2
- Efficacy and Safety of Omalizumab in Chronic Idiopathic UrticariaStatus unknownNCT02166151Phase 3
- Dietary Treatment for Chronic UrticariaTerminatedNCT02047136Not applicable
- A Pilot Single Dose Crossover Pharmacokinetics Study Of JDP-205 Injection, 10 mg, In Healthy Male And Female VolunteersCompletedNCT02045524Phase 1
- Safety, Tolerability and Pharmacokinetics Trial of JDP-205 Injection 10 mgCompletedNCT02024152Phase 1
- Efficacy Study of Omalizumab in Cholinergic UrticariaCompletedNCT02012387Phase 2
- Real-life Management and Therapeutic Outcome of Patients With Chronic Rhinitis and Chronic Urticaria in ThailandCompletedNCT02000648
- A Study of Quilizumab Versus Placebo in Patients With Refractory Chronic Spontaneous UrticariaCompletedNCT01987947Phase 2
- Methotrexate in the Treatment of Chronic Idiopathic UrticariaCompletedNCT01960283Phase 3
- Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin DiseasesStatus unknownNCT01952275
- Evaluation of the Inhibitory Effect of 5 Anti-Histamines in UrticariaCompletedNCT01940393Phase 4
- PK Comparisons of Bepotastine Besilate 10 mg and Bepotastine Salicylate 9.64 mgCompletedNCT01897428Phase 1
- PF and FeNO and Clinical Characteristics in Children Being Diagnosed Due to Suspicion of Allergic DiseasesStatus unknownNCT01805635
- Prospective Double-blind Placebo-controlled Study of the Effect of Xolair (Omalizumab) in Chronic Urticaria PatientsCompletedNCT01803763Phase 2/3
- Platelet Activation in Chronic Inflammatory Skin DiseasesStatus unknownNCT01759693
- Study of the Effects of Chinese Herbal Medicine on Chronic UrticariaCompletedNCT01715740Phase 3
- Efficacy and Safety Study of Omalizumab (Xolair®) to Treat Chronic UrticariaCompletedNCT01713725Phase 2
- Profiling Urticaria for the Identification of SubtypesCompletedNCT01637116
- Efficacy Study of Canakinumab to Treat UrticariaStatus unknownNCT01635127Phase 2
- Validation of an Urticaria Control TestCompletedNCT01614834
- Development of an Urticaria Control TestCompletedNCT01610128
- Study to Assess Efficacy, Safety and Mechanism of Rupatadine in Cold UrticariaCompletedNCT01605487Phase 2
- Desloratadine 5, 10 and 20mg in Patients With Cold UrticariaCompletedNCT01444196Phase 4
- T Cell Function in Chronic Idiopathic UrticariaStatus unknownNCT01425593
- Intravenous Immunoglobulins in Severe and Refractory Solar UrticariaCompletedNCT01360658Phase 2
- Bilastine Updosing - Characterization of Underlying MechanismsCompletedNCT01271075Phase 2/3
- Levocetirizine Plus Bed-Time Hydroxyzine in the Management of Corticodependent Chronic Urticaria Versus Levocetirizine Alone in High DosesCompletedNCT01250652Phase 4
- Ilaris® in Urticarial Vasculitis - Investigation of Treatment ResponsesCompletedNCT01170936Phase 2